Artículos de revistas sobre el tema "DAB2IP"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "DAB2IP".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Liu, Liang, Cong Xu, Jer-Tsong Hsieh, Jianping Gong y Daxing Xie. "DAB2IP in cancer". Oncotarget 7, n.º 4 (8 de diciembre de 2015): 3766–76. http://dx.doi.org/10.18632/oncotarget.6501.
Texto completoSun, Liang, Yizhou Yao, Ting Lu, Zengfu Shang, Shenghua Zhan, Weiqiang Shi, Guofeng Pan, Xinguo Zhu y Songbing He. "DAB2IP Downregulation Enhances the Proliferation and Metastasis of Human Gastric Cancer Cells by Derepressing the ERK1/2 Pathway". Gastroenterology Research and Practice 2018 (21 de marzo de 2018): 1–10. http://dx.doi.org/10.1155/2018/2968252.
Texto completoYu, Lan, Yue Lang, Ching-Cheng Hsu, Wei-Min Chen, Jui-Chung Chiang, Jer-Tsong Hsieh, Michael D. Story, Zeng-Fu Shang, Benjamin P. C. Chen y Debabrata Saha. "Mitotic phosphorylation of tumor suppressor DAB2IP maintains spindle assembly checkpoint and chromosomal stability through activating PLK1-Mps1 signal pathway and stabilizing mitotic checkpoint complex". Oncogene 41, n.º 4 (13 de noviembre de 2021): 489–501. http://dx.doi.org/10.1038/s41388-021-02106-8.
Texto completoQiao, Shuhong y Ramin Homayouni. "Dab2IP Regulates Neuronal Positioning, Rap1 Activity and Integrin Signaling in the Developing Cortex". Developmental Neuroscience 37, n.º 2 (2015): 131–41. http://dx.doi.org/10.1159/000369092.
Texto completoDuan, Yifan, Xiaoyu Yin, Xiaorong Lai, Chao Liu, Wenjing Nie, Dongfeng Li, Zijun Xie, Zijun Li y Fan Meng. "Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells". Technology in Cancer Research & Treatment 19 (1 de enero de 2020): 153303381989549. http://dx.doi.org/10.1177/1533033819895494.
Texto completoXu, He, Dapeng Wei, Jianxin Xue y Lijuan Hu. "A Novel Monoclonal Antibody Against Human DAB2IP". Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 34, n.º 4 (agosto de 2015): 251–56. http://dx.doi.org/10.1089/mab.2015.0011.
Texto completoPerurena, Naiara, Natalie Pilla, Amy Schade, Marina Watanabe, Patrick Loi, Carrie L. Rodriguez, Alycia M. Gardner y Karen Cichowski. "Abstract P1-13-06: Loss of emerging tumor and metastasis suppressor RasGAPs mediates therapeutic resistance in HER2+ breast cancer". Cancer Research 83, n.º 5_Supplement (1 de marzo de 2023): P1–13–06—P1–13–06. http://dx.doi.org/10.1158/1538-7445.sabcs22-p1-13-06.
Texto completoSu, Yintao, Fangyuan Shi, Zhanzhuang Zeng, Xiuling Wu, Yanhe Zhao, Lei Zhang, Zuofu Xie y Yunkun Wu. "A Versatile Monoclonal Antibody Specific Against Human DAB2IP". Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 34, n.º 4 (agosto de 2015): 246–50. http://dx.doi.org/10.1089/mab.2015.0012.
Texto completoDai, Xiangpeng, Brian J. North y Hiroyuki Inuzuka. "Negative regulation of DAB2IP by Akt and SCFFbw7 pathways". Oncotarget 5, n.º 10 (1 de mayo de 2014): 3307–15. http://dx.doi.org/10.18632/oncotarget.1939.
Texto completoLiu, S., N. Zhu y H. Chen. "Expression patterns of human DAB2IP protein in fetal tissues". Biotechnic & Histochemistry 87, n.º 5 (12 de marzo de 2012): 350–59. http://dx.doi.org/10.3109/10520295.2012.664658.
Texto completoLi, Xiaoning, Xiangpeng Dai, Lixin Wan, Hiroyuki Inuzuka, Liankun Sun y Brian J. North. "Smurf1 regulation of DAB2IP controls cell proliferation and migration". Oncotarget 7, n.º 18 (27 de marzo de 2016): 26057–69. http://dx.doi.org/10.18632/oncotarget.8424.
Texto completoLin, Chun-Jung, Andrew Dang, Elizabeth Hernandez y Jer-Tsong Hsieh. "DAB2IP modulates primary cilia formation associated with renal tumorigenesis". Neoplasia 23, n.º 1 (enero de 2021): 169–80. http://dx.doi.org/10.1016/j.neo.2020.12.002.
Texto completoHarrell Stewart, Desmond R., M. Lee Schmidt, Howard Donninger y Geoffrey J. Clark. "The RASSF1A Tumor Suppressor Binds the RasGAP DAB2IP and Modulates RAS Activation in Lung Cancer". Cancers 12, n.º 12 (17 de diciembre de 2020): 3807. http://dx.doi.org/10.3390/cancers12123807.
Texto completoWu, Kaijie, Daxing Xie, Yonglong Zou, Tingting Zhang, Rey-Chen Pong, Guanghua Xiao, Ladan Fazli et al. "The Mechanism of DAB2IP in Chemoresistance of Prostate Cancer Cells". Clinical Cancer Research 19, n.º 17 (9 de julio de 2013): 4740–49. http://dx.doi.org/10.1158/1078-0432.ccr-13-0954.
Texto completoXiao, Tian, Junchao Xue, Ming Shi, Chao Chen, Fei Luo, Hui Xu, Xiong Chen et al. "Circ008913,viamiR-889 regulation of DAB2IP/ZEB1, is involved in the arsenite-induced acquisition of CSC-like properties by human keratinocytes in carcinogenesis". Metallomics 10, n.º 9 (2018): 1328–38. http://dx.doi.org/10.1039/c8mt00207j.
Texto completoBellazzo, Arianna, Giulio Di Minin y Licio Collavin. "Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer". Cell Death & Differentiation 24, n.º 1 (18 de noviembre de 2016): 15–25. http://dx.doi.org/10.1038/cdd.2016.134.
Texto completoLee, Gum Hwa, Sun Hong Kim, Ramin Homayouni y Gabriella D'Arcangelo. "Dab2ip Regulates Neuronal Migration and Neurite Outgrowth in the Developing Neocortex". PLoS ONE 7, n.º 10 (4 de octubre de 2012): e46592. http://dx.doi.org/10.1371/journal.pone.0046592.
Texto completoHarrison, Seamus C., Jackie A. Cooper, Kawah Li, Phillipa J. Talmud, Reecha Sofat, Jeffery W. Stephens, Anders Hamsten et al. "Association of a sequence variant in DAB2IP with coronary heart disease". European Heart Journal 33, n.º 7 (28 de marzo de 2011): 881–88. http://dx.doi.org/10.1093/eurheartj/ehr075.
Texto completoDuan, Yi-Fan, Dong-Feng Li, Yan-Hui Liu, Ping Mei, Yu-Xuan Qin, Liang-Fang Li, Qiu-Xiong Lin y Zi-Jun Li. "Decreased expression of DAB2IP in pancreatic cancer with wild-type KRAS". Hepatobiliary & Pancreatic Diseases International 12, n.º 2 (abril de 2013): 204–9. http://dx.doi.org/10.1016/s1499-3872(13)60032-6.
Texto completoSon, Hyun Ji, Yun Sol Jo, Min Sung Kim, Nam Jin Yoo y Sug Hyung Lee. "DAB2IP with tumor-inhibiting activities exhibits frameshift mutations in gastrointestinal cancers". Pathology - Research and Practice 214, n.º 12 (diciembre de 2018): 2075–80. http://dx.doi.org/10.1016/j.prp.2018.10.005.
Texto completoXu, Yanting, Jiangtu He, Yue Wang, Xinyi Zhu, Qiuhui Pan, Qiuling Xie y Fenyong Sun. "miR-889 promotes proliferation of esophageal squamous cell carcinomas through DAB2IP". FEBS Letters 589, n.º 10 (1 de abril de 2015): 1127–35. http://dx.doi.org/10.1016/j.febslet.2015.03.027.
Texto completoZheng, Linfeng, Kaiyan Chen, Liang Zhu, Dan Su y Guoping Cheng. "Low expression of DAB2IP predicts an unfavorable prognosis in human bladder carcinoma". OncoTargets and Therapy Volume 10 (noviembre de 2017): 5719–26. http://dx.doi.org/10.2147/ott.s146952.
Texto completoBellazzo, Arianna y Licio Collavin. "A mechanism for cell non-autonomous inactivation of the tumor suppressor DAB2IP". Oncoscience 5, n.º 5-6 (29 de junio de 2018): 177–78. http://dx.doi.org/10.18632/oncoscience.441.
Texto completoZhou, Yunjiao, Zhenwei Yang, Hailin Zhang, Haiou Li, Meng Zhang, Haizhou Wang, Mengna Zhang, Peishan Qiu, Ruike Zhang y Jing Liu. "DNMT3A facilitates colorectal cancer progression via regulating DAB2IP mediated MEK/ERK activation". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1868, n.º 4 (abril de 2022): 166353. http://dx.doi.org/10.1016/j.bbadis.2022.166353.
Texto completoShan, Nan, Xiaoqiu Xiao, Ying Chen, Xin Luo, Nanlin Yin, Qinyin Deng y Hongbo Qi. "Expression of DAB2IP in human trophoblast and its role in trophoblast invasion". Journal of Maternal-Fetal & Neonatal Medicine 29, n.º 3 (21 de enero de 2015): 393–99. http://dx.doi.org/10.3109/14767058.2014.1001974.
Texto completoWu, K., J. Liu, S.-F. Tseng, C. Gore, Z. Ning, N. Sharifi, L. Fazli et al. "The role of DAB2IP in androgen receptor activation during prostate cancer progression". Oncogene 33, n.º 15 (22 de abril de 2013): 1954–63. http://dx.doi.org/10.1038/onc.2013.143.
Texto completoJacobs, Corbin, Vasu Tumati, Payal Kapur, Raquibul Hannan, Jer-Tsong Hsieh, Dong W. Kim y Debabrata Saha. "Association of decreased tumor DAB2IP and high-risk prostate cancer-specific survival." Journal of Clinical Oncology 34, n.º 15_suppl (20 de mayo de 2016): e16553-e16553. http://dx.doi.org/10.1200/jco.2016.34.15_suppl.e16553.
Texto completoQiao, Shuhong, Sun-Hong Kim, Detlef Heck, Daniel Goldowitz, Mark S. LeDoux y Ramin Homayouni. "Dab2IP GTPase Activating Protein Regulates Dendrite Development and Synapse Number in Cerebellum". PLoS ONE 8, n.º 1 (9 de enero de 2013): e53635. http://dx.doi.org/10.1371/journal.pone.0053635.
Texto completoSalami, Farimah, Shuhong Qiao y Ramin Homayouni. "Expression of mouse Dab2ip transcript variants and gene methylation during brain development". Gene 568, n.º 1 (agosto de 2015): 19–24. http://dx.doi.org/10.1016/j.gene.2015.05.012.
Texto completoWang, Guannan, Xu Wang, Meng Han y Xiaoming Wang. "Loss of DAB2IP Contributes to Cell Proliferation and Cisplatin Resistance in Gastric Cancer". OncoTargets and Therapy Volume 14 (febrero de 2021): 979–88. http://dx.doi.org/10.2147/ott.s289722.
Texto completoLuo, Xiaomin, Chunman Li, Ran Tan, Xiaohui Xu, William K. K. Wu, Ayano Satoh, Tuanlao Wang y Sidney Yu. "A RasGAP, DAB2IP, regulates lipid droplet homeostasis by serving as GAP toward RAB40C". Oncotarget 8, n.º 49 (3 de agosto de 2017): 85415–27. http://dx.doi.org/10.18632/oncotarget.19960.
Texto completoZhang, Tingting, Yijun Shen, Ying Chen, Jer-Tsong Hsieh y Zhaolu Kong. "The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect". International Journal of Radiation Biology 91, n.º 4 (6 de febrero de 2015): 368–78. http://dx.doi.org/10.3109/09553002.2015.1001531.
Texto completoFeng, Shengjie, Qingwen Huang, Jiao Deng, Weiyi Jia, Jianping Gong, Daxing Xie, Jie Shen y Liang Liu. "DAB2IP suppresses tumor malignancy by inhibiting GRP75-driven p53 ubiquitination in colon cancer". Cancer Letters 532 (abril de 2022): 215588. http://dx.doi.org/10.1016/j.canlet.2022.215588.
Texto completoXie, D., C. Gore, J. Liu, R. C. Pong, R. Mason, G. Hao, M. Long et al. "Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis". Proceedings of the National Academy of Sciences 107, n.º 6 (13 de enero de 2010): 2485–90. http://dx.doi.org/10.1073/pnas.0908133107.
Texto completoXie, D., C. Gore, J. Zhou, R. C. Pong, H. Zhang, L. Yu, R. L. Vessella, W. Min y J. T. Hsieh. "DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis". Proceedings of the National Academy of Sciences 106, n.º 47 (10 de noviembre de 2009): 19878–83. http://dx.doi.org/10.1073/pnas.0908458106.
Texto completoHomayouni, Ramin, Susan Magdaleno, Lakhu Keshvara, Dennis S. Rice y Tom Curran. "Interaction of Disabled-1 and the GTPase activating protein Dab2IP in mouse brain". Molecular Brain Research 115, n.º 2 (julio de 2003): 121–29. http://dx.doi.org/10.1016/s0169-328x(03)00176-1.
Texto completoQiao, Shuhong, Farimah Salami y Ramin Homayouni. "ISDN2014_0390: REMOVED: Dab2IP regulates neuronal migration and Rap1 activity in the developing cortex". International Journal of Developmental Neuroscience 47, Part_A (diciembre de 2015): 115. http://dx.doi.org/10.1016/j.ijdevneu.2015.04.310.
Texto completoHuang, Jun, Bin Wang, Ke Hui, Jin Zeng, Jinhai Fan, Xinyang Wang, Jer-Tsong Hsieh, Dalin He y Kaijie Wu. "miR-92b targets DAB2IP to promote EMT in bladder cancer migration and invasion". Oncology Reports 36, n.º 3 (15 de julio de 2016): 1693–701. http://dx.doi.org/10.3892/or.2016.4940.
Texto completoZong, Xingyue, Weini Wang, Ali Ozes, Fang Fang, George E. Sandusky y Kenneth P. Nephew. "EZH2-Mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells". Cancer Research 80, n.º 20 (19 de agosto de 2020): 4371–85. http://dx.doi.org/10.1158/0008-5472.can-20-0458.
Texto completoSamadaian, Niusha, Pouya Salehipour, Mohsen Ayati, Naser Rakhshani, Ali Najafi, Mandana Afsharpad, Fatemeh Yazarlou y Mohammad Hossein Modarressi. "A potential clinical significance of DAB2IP and SPRY2 transcript variants in prostate cancer". Pathology - Research and Practice 214, n.º 12 (diciembre de 2018): 2018–24. http://dx.doi.org/10.1016/j.prp.2018.09.019.
Texto completoPeng, Chih-Yu, Che-Yi Lin, Szu-Han Chen, Yi-Wen Liao, Cheng-Chia Yu y Shiao-Pieng Lee. "microRNA-1266-5p directly targets DAB2IP to enhance oncogenicity and metastasis in oral cancer". Journal of Dental Sciences 17, n.º 2 (abril de 2022): 718–24. http://dx.doi.org/10.1016/j.jds.2021.11.001.
Texto completoLEGAKI, EVANGELIA, CHRISTOS KLONARIS, DIMITRIOS ATHANASIADIS, NIKOLAOS PATELIS, ANNA SIOZIOU, THEODOROS LIAKAKOS y MARIA GAZOULI. "DAB2IP Expression in Abdominal Aortic Aneurysm: EZH2 and mir-363-3p as Potential Mediators". In Vivo 33, n.º 3 (2019): 737–42. http://dx.doi.org/10.21873/invivo.11533.
Texto completoLuo, Xiaomin, Chunman Li, Ran Tan, Xiaohui Xu, William K. K. Wu, Ayano Satoh, Tuanlao Wang y Sidney Yu. "Correction: A RasGAP, DAB2IP, regulates lipid droplet homeostasis by serving as GAP toward RAB40C". Oncotarget 9, n.º 17 (2 de marzo de 2018): 14035. http://dx.doi.org/10.18632/oncotarget.24600.
Texto completoYun, E.-J., S. T. Baek, D. Xie, S.-F. Tseng, T. Dobin, E. Hernandez, J. Zhou et al. "DAB2IP regulates cancer stem cell phenotypes through modulating stem cell factor receptor and ZEB1". Oncogene 34, n.º 21 (21 de julio de 2014): 2741–52. http://dx.doi.org/10.1038/onc.2014.215.
Texto completoValentino, Elena, Arianna Bellazzo, Giulio Di Minin, Daria Sicari, Mattia Apollonio, Giosuè Scognamiglio, Maurizio Di Bonito, Gerardo Botti, Giannino Del Sal y Licio Collavin. "Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP". Proceedings of the National Academy of Sciences 114, n.º 29 (30 de junio de 2017): 7623–28. http://dx.doi.org/10.1073/pnas.1700996114.
Texto completoZhang, Xiaojing, Ning Li, Xianzheng Li, Wei Zhao, Yudan Qiao, Li Liang y Yanqing Ding. "Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma". Journal of Gastroenterology and Hepatology 27, n.º 6 (24 de mayo de 2012): 1117–25. http://dx.doi.org/10.1111/j.1440-1746.2011.07049.x.
Texto completoXie, Daxing, Jun Liu, Crystal Gore, Guiyang Hao, Michael Long, Xiankai Sun y Jer-Tsong Hsieh. "THE IMPACT OF DAB2IP ON EPITHELIAL-MESENCHYMAL TRANSITION (EMT) LEADING TO PROSTATE CANCER METASTASIS". Journal of Urology 181, n.º 4S (abril de 2009): 512. http://dx.doi.org/10.1016/s0022-5347(09)61446-4.
Texto completoLiu, Jing, Meng Zhang, Cong Xu, Haizhou Wang, Ya N. Peng, Chang Gao, Lan Liu y Qiu Zhao. "Sa1198 - Mechanical Force Regulates Colorectal Tumorrepopulating Cells Self-Renewal Through Dab2Ip Mediated Nanog Expression". Gastroenterology 154, n.º 6 (mayo de 2018): S—275. http://dx.doi.org/10.1016/s0016-5085(18)31279-4.
Texto completoLIAO, HAIQIU, YANG XIAO, YINGBIN HU, YANGMING XIAO, ZHAOFA YIN y LIANG LIU. "microRNA-32 induces radioresistance by targeting DAB2IP and regulating autophagy in prostate cancer cells". Oncology Letters 10, n.º 4 (30 de julio de 2015): 2055–62. http://dx.doi.org/10.3892/ol.2015.3551.
Texto completoCao, Haoyuan, Jiandong Zhang y Wei Wang. "DAB2IP Plays Important Clinical Significance and Correlates With Immune Infiltration in Renal Cell Carcinoma". Technology in Cancer Research & Treatment 19 (1 de enero de 2020): 153303382093668. http://dx.doi.org/10.1177/1533033820936682.
Texto completo